Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Frost & Sullivan Recognizes GREENTECH SA for Its New Product Innovation in Cosmetics and Personal Care


News provided by

Frost & Sullivan

31 Oct, 2017, 10:30 GMT

Share this article

Share toX

Share this article

Share toX

GREENTECH's URBALYS® provides three unique protective functions in one skin care ingredient

SANTA CLARA, California, Oct. 31, 2017 /PRNewswire/ -- Based on its recent analysis of the cosmetics and personal care market, Frost & Sullivan recognizes GREENTECH SA with the 2017 European Frost & Sullivan Award for New Product Innovation. In April 2017, GREENTECH SA launched its URBALYS®, a new anti-pollution ingredient that combines three unique functions into one ingredient. This novel biological ingredient activates the skin's defense and cellular detoxification pathways while providing a barrier function, cellular defenses, and an anti-inflammatory response to combat the negative impacts of air pollution.

Click here for the full multi-media experience of this release - http://bit.ly/2wKhp8r

Increasing health concerns about air pollution have been the main driver for the cosmetic industry to introduce anti-pollution ingredients, such as plant extracts, polymer films, vitamins, and/or natural antioxidant complexes. At first designed for the Asian market, where pollution levels are high, the demand for cosmetics incorporating anti-pollution ingredients has been rising over the past few years in Western regions as well, providing attractive growth opportunities for ingredient manufacturers. Today's market is increasingly competitive, and diversification is crucial.

"GREENTECH has a proven track record in pioneering innovation for cosmetic ingredients," said Dr. Antonella Lisella-Wright at Frost & Sullivan. "As part of the GREENTECH Group, the company is one of the market leaders in developing ingredients from plants and biotechnology in the cosmetic and nutraceutical fields, often producing innovative ingredients every year in the GREENTECH laboratories. URBALYS® is the latest in a continuous stream of innovative products from the company, which just last year launched SOLIBERINE®, whole photo protector that prevents the formation of free radicals and reduces inflammation and cell apoptosis after exposure to UV, infrared and blue lights radiations."

The company's newest ingredient, URBALYS®, is different from other products in the anti-pollution skin care market because it is an all-in-one protection ingredient which protects skin tissue against all urban pollution forms: Activates the skin's defense and cellular detoxification pathways, while providing a barrier function, cellular defenses, and an anti-inflammatory response. It does so by activating the cell signal pathways of the nuclear factor (erythroid-derived 2)-like 2 (Nrf2) and by decreasing activity of the Nuclear Factor-KB (NF-KB), which are the two key transcription factors that regulate cellular responses to oxidative stress and inflammation, respectively.

A pioneer in plant biotechnology when created in 1992, GREENTECH develops and produces for the cosmetic, pharmaceutical and nutraceutical sectors, high-tech active ingredients originating from the deep mechanisms of plants, algae, micro-algae and micro-organisms drawn from across the world. One company is dedicated to each bio universe: GREENTECH (Botanical), GREENSEA (Marine), BIOVITIS (Microbial), MAPRIC (Brazilian Biodiversity) and has 3 subsidiaries in USA, Germany, and Brazil.

GREENTECH is present on all continents and more than 30 countries across the world thanks to a network of local distributors. Its strong focus on research and development (R&D), GREENTECH has expanded its database with the discovery of over 30,000 plants and 300,000 biological molecules for the development of new, targeted active ingredients. This expansive database, coupled with GREENTECH's unique pharmaceutical approach to develop cosmetic ingredients, allows GREENTECH to develop high-quality products that meet or exceed customer needs and offer significant advantages over similar ingredients currently on the market.

"Most companies today have to create a combination of different ingredients in the same cosmetic formulation to achieve the same amount of protection as URBALYS®," said Wright. "GREENTECH has long-standing experience in combining natural ingredients with biotechnology and bioinformatics, which allowed it to develop URBALYS®. This innovative ingredient offers measurable value to end users by providing a multi-purpose skin care ingredient that offers protection against pollution, anti-aging properties by eliminating free radicals, an increase in the skin's natural defense, and anti-inflammatory properties."

GREENTECH has a proven track record in pioneering innovation for cosmetic ingredients in a crowded, competitive cosmetics and personal care market. Frost & Sullivan commends GREENTECH for developing URBALYS®, an innovative three-in-one anti-pollution ingredient that offers a strong value proposition to customers and positions GREENTECH as a top contender in the cosmetics anti-pollution ingredient market.

Each year, Frost & Sullivan presents this award to the company that has developed an innovative product by leveraging leading-edge technologies. The award recognizes the value-added features/benefits of the product and the increased ROI it gives customers, which, in turn, raises customer acquisition and overall market penetration potential.

Frost & Sullivan Best Practices awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research to identify best practices in the industry.

About GREENTECH SA

A pioneer in plant biotechnology when created in 1992, GREENTECH develops and produces for the cosmetic, pharmaceutical and nutraceutical sectors, high-tech active ingredients originating from the deep mechanisms of plants, algae, micro-algae and micro-organisms drawn from across the world. One company is dedicated to each bio universe: GREENTECH (Botanical), GREENSEA (Marine), BIOVITIS (Microbial) & MAPRIC (Brazilian Biodiversity). It's present on all continents and more than 30 countries across the world thanks to a network of local distributors.

Contact: Jean-Yves Berthon
E: jeanyvesberthon@greentech.fr

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants. For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Contact us: Start the discussion.

Contact:

Estefany Ariza
P: 210.277.8469
F: 210.348.1003
E: estefany.ariza@frost.com


 

Related Links

http://www.frost.com

Modal title

Also from this source

Avance Clinical Honored with Frost & Sullivan's 2025 Global Customer Value Leadership Award for Transformative Biotech CRO Services

Avance Clinical Honored with Frost & Sullivan's 2025 Global Customer Value Leadership Award for Transformative Biotech CRO Services

Frost & Sullivan has named Avance Clinical the recipient of its 2025 Global Customer Value Leadership Award in the biotech contract research...

Frost & Sullivan Launches MetaBrain

Frost & Sullivan Launches MetaBrain

In a landmark announcement, Frost & Sullivan, in collaboration with SAP, introduced MetaBrain, a Human-Reinforced Agent powered by Frost & Sullivan's ...

More Releases From This Source

Explore

Retail

Retail

Health Care & Hospitals

Health Care & Hospitals

Biotechnology

Biotechnology

Awards

Awards

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.